- Home
- REPL vs HUYA Comparison
REPL vs HUYA Comparison
Compare REPL & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REPL | HUYA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.8M | 753.7M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | REPL | HUYA |
|---|---|---|
| Price | $5.34 | $3.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $5.67 | $3.50 |
| AVG Volume (30 Days) | ★ 8.1M | 626.0K |
| Earning Date | 05-21-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 81.37% |
| EPS Growth | ★ 5.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.08 |
| Revenue Next Year | N/A | $6.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $2.21 |
| 52 Week High | $13.24 | $4.93 |
Technical Indicators
Market Signals| Indicator | REPL | HUYA |
|---|---|---|
| Relative Strength Index (RSI) | 62.53 | 44.79 |
| Support Level | $4.39 | $2.86 |
| Resistance Level | $5.84 | $3.13 |
| Average True Range (ATR) | 0.53 | 0.12 |
| MACD | 0.43 | 0.01 |
| Stochastic Oscillator | 96.61 | 36.76 |
Price Performance
Historical ComparisonAbout REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.